XML 36 R27.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activity

The following table summarizes stock option activity for the three months ended March 31, 2025 (in thousands, except share and per share amounts):

 

Number of Options

 

 

Weighted Average
Exercise Price

 

 

Weighted Average
Remaining Contractual
Term (Years)

 

 

Aggregate
Intrinsic Value

 

Outstanding at January 1, 2025

 

9,711,075

 

 

$

5.04

 

 

 

8.2

 

 

$

44

 

Granted

 

3,104,372

 

 

 

0.98

 

 

 

 

 

 

 

Forfeited

 

(587,279

)

 

 

2.01

 

 

 

 

 

 

 

Outstanding at March 31, 2025

 

12,228,168

 

 

$

4.16

 

 

 

8.2

 

 

$

21

 

Options exercisable March 31, 2025

 

4,379,232

 

 

$

7.00

 

 

 

6.2

 

 

$

21

 

Schedule of Estimated Fair Value Assumptions

 

Three Months Ended March 31,

 

2025

 

2024

 

Expected volatility

93.920% - 99.910%

 

99.41% - 102.27%

 

Risk-free interest rate

3.960% - 4.450%

 

4.06% - 4.23%

 

Expected dividend yield

0.00%

 

0.00%

 

Expected term (in years)

5.00 - 6.08

 

5.00 - 6.08

 

 

Summary of Restricted Stock Awards and Restricted Stock Units

The following table summarizes restricted stock units activity for the three months ended March 31, 2025:

 

 

Number of Shares

 

 

Weighted Average
Grant Date Fair Value

 

Outstanding at January 1, 2025

 

2,533,650

 

 

$

3.26

 

Forfeited

 

(80,804

)

 

 

3.18

 

Vested and settled

 

(30,892

)

 

 

3.73

 

Outstanding at March 31, 2025(1)

 

2,421,954

 

 

$

3.26

 

 

(1) Includes 361,263 RSUs which are vested but not settled at March 31, 2025.

Summary of Total Stock-based Compensation Expense

The following table summarizes the total stock-based compensation expense for the three months ended March 31, 2025 and 2024, respectively (in thousands):

 

Three Months Ended March 31,

 

 

2025

 

 

2024

 

General and administrative

 

$

2,509

 

 

$

3,642

 

Research and development

 

 

1,122

 

 

 

678

 

Total

 

$

3,631

 

 

$

4,320